Impact of High Volume Hemofiltration on Hemodynamic Disturbance and Outcome during Septic Shock

ASAIO Journal

Volumn 50, Issue 1, 2004, Pages 102-109

  Joannes Boyau, Olivier ^a   Rapaport, Stephane ^a   Bazin, Romain ^a   Fleureau, Catherine ^a   Janvier, Gerard ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTENSIVE CARE UNITS; PATIENT MONITORING; ULTRAFILTRATION;

SEPTIC SHOCKS;

HEMODYNAMICS;

NORADRENALIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HEMOFILTRATION; HIGH VOLUME CONTINUOUS VENOVENOUS HEMOFILTRATION; HUMAN; INTENSIVE CARE; MALE; MORTALITY; SCORING SYSTEM; SEPTIC SHOCK; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BILIRUBIN; CREATININE; FACTOR V; FEMALE; HEMODYNAMIC PROCESSES; HEMOFILTRATION; HUMANS; MALE; MIDDLE AGED; OXYGEN; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0347320804     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000104846.27116.EA     Document Type: Article

References (36)

1. Parillo J: Pathogenic mechanisms of septic shock. N Engl J Med 328: 1471-1477, 1993.
2. Edwards JD, Brown GC, Nightingale P, et al: Use of survivors' cardiorespiratory values as therapeutic goals in septic shock. Crit Care Med 17: 1098-1103, 1989.
3. Bernard GH, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for treatment of patients with severe sepsis. N Engl J Med 344: 699-709, 2001.
4. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862-871, 2002.
5. Yildiz O, Doganay M, Aygen B, et al: Physiological-dose steroid therapy in sepsis. Crit Care Med 6: 251-259, 2002.
6. Oppert M, Reinicke A, Graf KJ, Barckow D, Frei U, Eckardt KU: Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med 26: 1747-1755, 2000.
7. Honore PM, Jamez J, Wauthier M, et al: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28: 3581-3587, 2000.
8. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA: The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27: 1416-1421, 2001.
9. Abid O, Akca S, Haji-Michael P, Vincent JL: Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure. Crit Care Med 28: 947-949, 2000.
10. Bone RC: The pathogenesis of sepsis. Ann Intern Med 115: 457-469, 1991.
11. Calandra T, Baumgartner JD, Grau GE, et al: Prognostic value of tumor necrosis factor, interleukin 1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. J infect Dis 161: 982-987, 1990.
12. Grootendorst AF, van Bommel EF, van Leengoed LA, Nabuurs M, Bouman CS, Groeneveld AB: High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 2: 72-78, 1994.
13. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-1377, 2001.
14. Schmidt HB, Werdan K, Muller-Werdan U: Autonomic dysfunction in the ICU patient. Curr Opin Crit Care 7: 314-322, 2001.
15. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P: High-volume haemofiltration in human septic shock. Intensive Care Med 27: 978-986, 2001.
16. Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL: Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 27: 1848-1855, 1999.
17. Bone RC: Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med 114: 332-333, 1991.
18. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Int Care Med 22: 707-710, 1996.
19. Vincent JL, de Mendonca A, Cantraine F, et al: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on sepsis-related problems of the European Society of Intensive Care Medicine. Crit Care Med 26: 1793-1800, 1998.
20. Le Gall JR, Klar J, Lemeshow S, et al: The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 276: 802-810, 1996.
21. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23: 1638-1652, 1995.
22. Pettila V, Pettila M, Sarna S, et al: Comparison of multiple organ dysfunction scores in the prediction of hospital mortality in the critically ill. Crit Care Med 30: 1705-1711, 2002.
23. Ferreira FL, Bota DP, Bross A: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286: 1754-1758, 2001.
24. Task Force of the American College of Critical Care Medicine S. o. C. C. M.: Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 29: 637-660, 1999.
25. Dhainaut JF, MN, Cariou A: Prise en charge hémodynamique du choc septique en réanimation adulte, in Conf Actual SFAR. St. Louis, MO: Elsevier, 1998; pp. 339-348.
26. Martin C, Saux P, Eon B, et al: Septic shock: a goal directed therapy using volume loading, dobutamine and/or norepinephrine. Acta Anaesthesiol Scand 34: 413-417, 1990.
27. De Vriese AS, Vanholder RC, Pascual M, et al: Can inflammatory cytokines he removed efficiently by continuous renal replacement therapies? Intensive Care Med 25: 903-910, 1999.
28. Kellum JA: Immunomodulation in sepsis: the role of hemofiltration. Minerva Anestesiol 65: 410-418, 1999.
29. Kellum JA, Johnson JP, Kramer D, et al: Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 26: 1995-2000, 1998.
30. Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P: Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med 21: 169-176, 1995.
31. Weksler N, et al. Continuous venovenous hemofiltration improves intensive care unit, but not hospital survival rate, in nonoliguric septic patients. J Crit Care 16: 69-73, 2001.
32. Murphey ED, Fessler JF, Bottoms GD, et al: Effects of continuous venovenous hemofiltration on cardiopulmonary function in a porcine model of endotoxin-induced shock. Am J Ver Res 58: 408-413, 1997.
33. Ronco C, et al. Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356: 26-30, 2000.
34. Jamal JA, Joh J, Bastani B, et al: Removal of morphine with the new high efficiency and high flux membranes during haemofiltration and haemodiafiltration. Nephrol Dial Transplant 13: 1535-1537, 1998.
35. Cole L, Bellomo R, Hart G, et al: A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 30: 100-106, 2002.
36. Russell JA, Singer J, Bernard GR, et al: Changing pattern of organ dysfunction in early human sepsis is related to mortality. Crit Care Med 28: 3405-3411, 2000.